BNP Paribas Financial Markets Portfolio holdings
BNP Paribas Financial Markets, a core component of BNP Paribas’s Corporate & Institutional Banking (CIB) division, is a global leader in trading and market-making, headquartered in Paris with major hubs in London, New York, Hong Kong, and Singapore. Specializing in derivatives across all asset classes—equities, fixed income, commodities, and foreign exchange—it provides innovative investment, hedging, and financing solutions to corporate clients, institutional investors, and financial institutions worldwide. Known for its advanced technological infrastructure and quantitative expertise, the division excels in structured financing and electronic trading, supported by a robust balance sheet and a diversified business model that proved resilient during the 2008 financial crisis. With a presence in over 50 countries and a client base exceeding 13,000, BNP Paribas Financial Markets drives market liquidity and offers cutting-edge research and execution services, reinforcing its position as a top-tier player in global capital markets.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Berkshire Hathaway Class A
BRK.A
|
+$255B |
| 2 |
Thermo Fisher Scientific
TMO
|
+$458M |
| 3 |
Alphabet (Google) Class C
GOOG
|
+$288M |
| 4 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$199M |
| 5 |
Advanced Micro Devices
AMD
|
+$158M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$622M |
| 2 |
Microsoft
MSFT
|
+$543M |
| 3 |
Alphabet (Google) Class A
GOOGL
|
+$533M |
| 4 |
Amazon
AMZN
|
+$353M |
| 5 |
Diageo
DEO
|
+$303M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 10.41% |
| 2 | Financials | 6.24% |
| 3 | Healthcare | 5.83% |
| 4 | Consumer Discretionary | 5.56% |
| 5 | Industrials | 3.98% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
3701
Goldman Sachs ActiveBeta International Equity ETF
GSIE
$6.16B
| $49.8K | ﹤0.01% |
+2,013
| New | +$55.9K |
|
|
SKYT
3702
DELISTED
SkyWater Technology
SKYT
| $49.7K | ﹤0.01% |
+6,500
| New | +$76.6K |
|
3703
Duluth Holdings
DLTH
$151M
| $49.7K | ﹤0.01% |
7,055
+633
| +10% | +$5.66K |
|
|
BBLN
3704
DELISTED
Babylon Holdings Limited
BBLN
| $49.3K | ﹤0.01% |
+4,172
| New | +$85.3K |
|
|
AVEO
3705
DELISTED
AVEO Pharmaceuticals, Inc.
AVEO
| $49.3K | ﹤0.01% |
+5,985
| New | +$46K |
|
3706
Roivant Sciences
ROIV
$26.2B
| $48.9K | ﹤0.01% |
+15,200
| New | +$58.9K |
|
3707
Angi Inc
ANGI
$176M
| $48.6K | ﹤0.01% |
1,648
-4,637
| -74% | -$204K |
|
3708
CALL
US Bancorp
USB
$101B
| $48.4K | ﹤0.01% |
12
| – | – |
|
|
ALPN
3709
DELISTED
Alpine Immune Sciences Inc
ALPN
| $47.3K | ﹤0.01% |
6,572
+3,090
| +89% | +$25.5K |
|
3710
Puma Biotechnology
PBYI
$450M
| $47.2K | ﹤0.01% |
19,918
+6,212
| +45% | +$18.1K |
|
3711
Shinhan Financial Group
SHG
$34.6B
| $46.9K | ﹤0.01% |
2,039
+1,575
| +339% | +$41.7K |
|
3712
Unity Bancorp
UNTY
$619M
| $46.7K | ﹤0.01% |
1,858
+161
| +9% | +$4.42K |
|
|
JNCE
3713
DELISTED
Jounce Therapeutics, Inc. Common Stock
JNCE
| $46.5K | ﹤0.01% |
19,876
+10,761
| +118% | +$38.1K |
|
|
SVM
3714
Silvercorp Metals
SVM
$2.68B
| $46.5K | ﹤0.01% |
19,953
-2,071
| -9% | -$4.98K |
|
3715
Future Fuel
FF
$249M
| $46.5K | ﹤0.01% |
7,694
-43,298
| -85% | -$299K |
|
|
SA
3716
Seabridge Gold
SA
$3.5B
| $46.4K | ﹤0.01% |
3,913
| – | – |
|
|
CCLP
3717
DELISTED
CSI Compressco LP
CCLP
| $46.3K | ﹤0.01% |
39,564
-24,966
| -39% | -$31.4K |
|
|
SBDS
3718
DELISTED
Solo Brands Inc
SBDS
| $45.8K | ﹤0.01% |
+301
| New | +$56.3K |
|
3719
Scholar Rock
SRRK
$6.55B
| $45.7K | ﹤0.01% |
6,588
-13,695
| -68% | -$114K |
|
3720
First Guaranty Bancshares
FGBI
$139M
| $45.4K | ﹤0.01% |
2,073
+656
| +46% | +$15.6K |
|
3721
Samsara
IOT
$24B
| $45K | ﹤0.01% |
+3,727
| New | +$52.8K |
|
3722
Precision BioSciences
DTIL
$205M
| $44.7K | ﹤0.01% |
1,145
+138
| +14% | +$6.56K |
|
3723
P3 Health Partners
PIII
$38.9M
| $44.5K | ﹤0.01% |
+193
| New | +$48.3K |
|
3724
CALL
Hershey
HSY
$37B
| $44.1K | ﹤0.01% |
2
| – | – |
|
3725
Richardson Electronics
RELL
$302M
| $44K | ﹤0.01% |
+2,917
| New | +$46.1K |
|
Similar funds
BNP Paribas Financial Markets's Q3 2022 Portfolio in Review
As of Q3 2022, BNP Paribas Financial Markets held 5,152 positions worth $62.5B, down 2.4% from $64.1B the previous quarter. Its ten largest holdings account for 12% of the portfolio.
BNP Paribas Financial Markets deployed $254B of net new capital in Q3 2022, opening 1,204 new positions and adding to 1,887 existing holdings. Its largest new stake was Marvell Technology: 910,010 shares worth $39M.
By sector, the portfolio is most concentrated in Technology at 10% of assets, down from 14% a quarter earlier, followed by Financials and Healthcare.
On the sell side, the largest reduction was Apple, an estimated $622M trimmed.
- BNP Paribas Financial Markets's largest Q3 2022 buy was Marvell Technology: 910,010 shares worth $39M.
- BNP Paribas Financial Markets added most to Berkshire Hathaway Class A in Q3 2022, an estimated $255B increase.
- BNP Paribas Financial Markets's biggest Q3 2022 reduction was Apple, cutting an estimated $622M.
- BNP Paribas Financial Markets fully exited Alphabet (Google) Class A in Q3 2022, selling an estimated $533M.
- BNP Paribas Financial Markets's ten largest holdings make up 12% of its $62.5B portfolio in Q3 2022.
- BNP Paribas Financial Markets opened 1,204 new positions and closed 420 in Q3 2022.
- BNP Paribas Financial Markets's portfolio value fell 2.4% quarter-over-quarter to $62.5B.
Based on BNP Paribas Financial Markets's 13F filing for Q3 2022, filed 15 Nov 2022.